Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

NCT02787304 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

197

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Steatohepatitis

Interventions

DRUG: SHP626
DRUG: Placebo

Sponsor

Mirum Pharmaceuticals, Inc.